N-[4-chloro-2-fluoro-3-[2-(piperidin-3-ylamino)quinazolin-6-yl]phenyl]-1-phenylmethanesulfonamide
C26H25ClFN5O2S — CID 155391742
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-chloro-2-fluoro-3-[2-(piperidin-3-ylamino)quinazolin-6-yl]phenyl]-1-phenylmethanesulfonamide
N-[4-chloro-2-fluoro-3-[2-(piperidin-3-ylamino)quinazolin-6-yl]phenyl]-1-phenylmethanesulfonamide (PubChem CID 155391742) has the molecular formula C26H25ClFN5O2S and a molecular weight of 526.04 g/mol. Its IUPAC name is N-[4-chloro-2-fluoro-3-[2-(piperidin-3-ylamino)quinazolin-6-yl]phenyl]-1-phenylmethanesulfonamide.
Molecular Properties
| Compound Name | N-[4-chloro-2-fluoro-3-[2-(piperidin-3-ylamino)quinazolin-6-yl]phenyl]-1-phenylmethanesulfonamide |
|---|---|
| PubChem CID | 155391742 |
| Molecular Formula | C26H25ClFN5O2S |
| Molecular Weight | 526.04 g/mol |
| Exact Mass | 525.14 |
| IUPAC Name | N-[4-chloro-2-fluoro-3-[2-(piperidin-3-ylamino)quinazolin-6-yl]phenyl]-1-phenylmethanesulfonamide |
| SMILES | O=S(=O)(Cc1ccccc1)Nc1ccc(Cl)c(-c2ccc3nc(NC4CCCNC4)ncc3c2)c1F |
| InChI | InChI=1S/C26H25ClFN5O2S/c27-21-9-11-23(33-36(34,35)16-17-5-2-1-3-6-17)25(28)24(21)18-8-10-22-19(13-18)14-30-26(32-22)31-20-7-4-12-29-15-20/h1-3,5-6,8-11,13-14,20,29,33H,4,7,12,15-16H2,(H,30,31,32) |
| InChIKey | HPTBANYNILHJOI-UHFFFAOYSA-N |
| XLogP | 5.20 |
| TPSA | 96.01 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 526.04 |
| LogP ≤ 5 | 5.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155391742 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.